Figure 1 Bills Included in the Data Set, by Type and Session of Congress Source : Data collected by authors from Congress.gov More

Figure 1 Criteria for Determining the Type of California Department of Managed Health Care Regulation for Health Plans and Providers Source : Authors' analysis of Knox-Keene Act, Department of Managed Health Care regulations, and key informant interviews Notes : The term provider includes More

Figure 2 Number of ACOs by Insurance Type in California, August 2012–February 2014 Source : Authors' analysis of Cattaneo and Stroud, ACO Activities in California (2012–14) More

Figure 3 Number of Lives Covered by ACOs by Insurance Type in California, August 2012–February 2014 Source : Authors' analysis of Cattaneo and Stroud, ACO Activities in California (2012–14) More

Figure 4 Percentage of Californians Covered by an ACO by Insurance Type, August 2012–February 2014 Source : Authors' analysis of Cattaneo and Stroud, ACO Activities in California (2012–14) Notes : The figure shows the share of California's Medicare fee-for-service beneficiaries covered More

Figure 1 Expected Years to Adoption, by Seed Ensemble Type (Five Seeds) Notes : Bars represent the average years to adoption. We calculated these by taking the average years to adoption within each draw and then averaging across draws. The black capped lines represent 95 percent confidence More

Figure 3 Marginal effects of drug deaths on treatment sponsorship by drug type/race of victim: (a) all drugs; (b) opioids; (c) cocaine; (d) methamphetamine; (e) white victims; (f) black victims. Notes : Marginal effects of drug deaths on sponsorship of one or more bills related to treatment More

Figure 3 Marginal effects of drug deaths on treatment sponsorship by drug type/race of victim: (a) all drugs; (b) opioids; (c) cocaine; (d) methamphetamine; (e) white victims; (f) black victims. Notes : Marginal effects of drug deaths on sponsorship of one or more bills related to treatment More

Figure 3 Marginal effects of drug deaths on treatment sponsorship by drug type/race of victim: (a) all drugs; (b) opioids; (c) cocaine; (d) methamphetamine; (e) white victims; (f) black victims. Notes : Marginal effects of drug deaths on sponsorship of one or more bills related to treatment More

Figure 2 Percent of Nonelderly US population (< 65 Years), by Coverage Type, 2010–2018 Source : National Center for Health Statistics, 2019 ; National Health Interview Survey: Long-Term Trends in Health Insurance Coverage, 1968–2018. More

Figure 3 Type of abortion regulation addressed in state court cases by state legislature party control (2000–2021). More

Figure 1 Preenrollment Opinion on Three Measures of ACA Support, by Postenrollment Insurance Type. More

Figure 7 Vote for and Support for Democratic Candidates in the 2014 House Midterm Elections by Insurance Type. Notes : Data are recycled predictions and their 95% Huber-White confidence intervals from regressions of insurance type. The dashed lines indicate predicted outcomes among individuals More

Figure 3 Coverage continuity for disenrolled and new Medicaid cohorts, April 2014–December 2016. a) Medicaid enrollees disenrolled in April 2014. b) New Medicaid enrollees in April 2014. Notes : Continuous insurance combines any type of full-benefit coverage (commercial, Medicaid, and other More

Figure 2 Predicted Postenrollment (Dark Points) and August (Light Points) ACA Opinion by Insurance Type. Notes : Data are recycled predictions and their 95% Huber-White confidence intervals from regressions of insurance type. The dashed lines indicate predicted postenrollment and August ACA More

Figure 1 Predicted Likelihood of Internet as Go-To Source of Health Information When in Need by Race and Insurance Type, Adjusted Model More

Figure 3 Predicted Likelihood of Internet as Go-To Source of Health Information by Insurance Type and Mobile Device Access, Adjusted Model More